Literature DB >> 2880098

Standardising the anti-cardiolipin antibody test.

E N Harris, G R Hughes.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2880098     DOI： 10.1016/s0140-6736(87)90099-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study.

Authors:  L Naldi; F Locati; L Marchesi; S Cortelazzo; G Finazzi; M Galli; A Brevi; T Cainelli; T Barbui
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

2.  Detection of anti-bovine beta 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome.

Authors:  M Nomura; J Okada; H Kondo
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

3.  Anticardiolipin antibodies in ischaemic heart disease: marker or myth?

Authors:  K V Phadke; R A Phillips; D T Clarke; M Jones; P Naish; P Carson
Journal:  Br Heart J       Date:  1993-05

4.  Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.

Authors:  Elin S Gray; Natasha Taylor; Diane Wycuff; Penny L Moore; Georgia D Tomaras; Constantinos Kurt Wibmer; Adrian Puren; Allan DeCamp; Peter B Gilbert; Blake Wood; David C Montefiori; James M Binley; George M Shaw; Barton F Haynes; John R Mascola; Lynn Morris
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

5.  Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.

Authors:  Lynn Morris; Xi Chen; Munir Alam; Georgia Tomaras; Ruijun Zhang; Dawn J Marshall; Bing Chen; Robert Parks; Andrew Foulger; Frederick Jaeger; Michele Donathan; Mira Bilska; Elin S Gray; Salim S Abdool Karim; Thomas B Kepler; John Whitesides; David Montefiori; M Anthony Moody; Hua-Xin Liao; Barton F Haynes
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

6.  Effectiveness of high-dose i.v. immunoglobulin therapy for pregnant women with aspirin-heparin-resistant secondary antiphospholipid syndrome.

Authors:  Yoko Maesawa; Masashi Deguchi; Kenji Tanimura; Mayumi Morizane; Yasuhiko Ebina; Hideto Yamada
Journal:  Reprod Med Biol       Date:  2018-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.